The conundrum of dietary antioxidants in cancer chemotherapy

Nutr Rev. 2020 Jan 1;78(1):65-76. doi: 10.1093/nutrit/nuz027.

Abstract

Although chemotherapy succeeds in reducing tumor burden, the efficacy is limited due to acquired drug resistance and often irreparable side effects. Studies show that antioxidants may influence the response to chemotherapy and its side effects, although their use remains controversial. The evidence shows that some chemo-drugs induce oxidative stress and lead to normal tissue apoptosis and the entry of cancer cells to a dormant G0 state. Through the suppression of oxidative stress, antioxidants could protect normal cells and bring the tumor out of dormancy so as to expose it to chemotherapies. This review is focused on the redox biology of cancer/normal cells and association of reactive oxygen species with drug resistance, cancer dormancy, and side effects. To this end, evidence from cellular, animal, and clinical studies is provided to better understand the conundrum of dietary antioxidants in cancer chemotherapy.

Keywords: antioxidants; cancer chemotherapy; carotenoids; oxidative stress; side effect.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Antioxidants / pharmacology*
  • Diet*
  • Drug Resistance, Neoplasm
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Neoplasms / metabolism*
  • Neoplasms / prevention & control
  • Primary Prevention
  • Reactive Oxygen Species / metabolism

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Reactive Oxygen Species